The Audit Intelligence Compliance Assistant is AI purpose-built for pharma and biologic compliance auditing. Unlike generic AI tools, AICA was trained by 15+ regulatory professionals on real quality documentation. Upload your policies and procedures, select which regulations to audit against, and AICA identifies gaps between what your documents say and what regulations require—in minutes or hours instead of days or weeks.
AICA is trained on the depth, rigor, and repeatable patterns behind The FDA Group’s most thorough FDA audits, not surface-level checklists, or generic compliance rules.
Reviews large volumes of documentation with the same discipline, judgment, and consistency applied by The FDA Group’s audit teams, delivered at AI scale.
Enables teams to initiate and complete audit-grade analyses without waiting for traditional audit timelines or external scheduling constraints.
Produces structured, decision-ready outputs aligned to The FDA Group’s audit methodology, minimizing interpretation gaps and follow-up cycles.
Reduces manual review burden while raising the overall depth and consistency of audit outcomes, allowing teams to do more with fewer internal resources.
AICA was born from a simple frustration: the AI tools entering our industry weren’t built by people who actually do this work. They’re built by tech companies trying to sell to life sciences, not by regulatory professionals solving real compliance problems.
We took a different approach. Our AI was trained by regulatory experts who’ve conducted thousands of audits. They know what regulators actually look for, not just what the regulations say. That expertise is AICA’s foundation, and it’s why we’re confident this platform will transform how companies approach compliance auditing.”
Customize each audit by selecting specific regulatory requirements. Focus on the regulations that matter most for your products and markets.
Planning to expand into a new market? Run a gap analysis against the specific requirements before you submit. Preparing for an FDA inspection focused on Part 11? Audit just those requirements. AICA adapts to your compliance priorities.
AICA processes thousands of pages of documentation. What used to require pulling employees off projects for week-long internal audits now happens at machine speed.
Upload documents individually or in batches. AICA immediately flags non-conformances, suggests remediation strategies, and generates prioritized action lists. Finally you can take a step toward proactive compliance monitoring across your entire QMS.
Every AICA analysis generates a series of detailed compliance reports with a gap analysis, specific CFR references, prioritized observations, and executive dashboards with heat maps.
These reports support internal audits, supplier audits, and preparation for regulatory inspections. Each finding includes the specific clause, the non-conforming document, a clear explanation of the gap, and detailed corrective action recommendations.
Quickly identify exactly where your team or an external auditor should direct time and attention.
1+ week of dedicated auditor time
~10-20% document coverage
Annual/Semi-annual frequency
Days to weeks to generate reports
Sampling methodology
Just hours to process the entire QMS
100% document coverage
Instant report generation
Comprehensive analysis
Consistent methodology everywhere
Upload policies, procedures, work instructions, and forms.
Choose which requirements to audit against.
AICA compares your docs against regulatory requirements.
Quality expert reviews AI-generated observations.
Download audit-ready compliance reports.
AICA currently supports pharma and biologic compliance auditing, with full coverage of 21 CFR Parts 11, 211, and 600, and additional clinical-focused CFR parts and ICH guidance documents in active development.
Expansion into medical device regulatory frameworks including ISO 13485 and FDA QMSR (21 CFR Part 820) is planned as part of AICA's product roadmap. While these modules are not yet available, development sequencing is underway and we anticipate phased expansion based on customer demand and partnership opportunities.
If medical device compliance is a priority for your organization, we're actively seeking partner organizations to help shape and validate these new modules. Partnering organizations contribute real-world QMS documentation that helps us build more accurate, practical coverage and get early access to new regulation modules as they're developed. Contact our team to discuss roadmap alignment for devices.
Absolutely. AICA is built on a secure, cloud-based infrastructure with enterprise-grade encryption for all data transmissions. Your confidential documents are stored in isolated, access-controlled environments. AICA was trained exclusively on curated biopharma QMS documents explicitly provided for that purpose by regulatory experts. You retain complete ownership and control of your documentation at all times.
For organizations with stringent security requirements, AICA can be deployed on your own private cloud infrastructure, ensuring your documents never leave your controlled environment.
Yes. You have full control over document retention. Documents can be deleted immediately after AICA completes its analysis if you prefer not to store them in the platform. You can also configure automated deletion policies based on your organization's data retention requirements.
Analysis reports and the observations they contain remain in your secure AICA workspace until you choose to delete them. These reports do not contain your actual QMS documents—only references to them, along with the gap analysis and recommendations. You can export reports at any time and manage them according to your internal document control procedures.
Yes, and here's why we're confident. AICA was trained using real-world pharma QMS documents and validated against known compliance gaps. To put AICA's performance in context, when expert human auditors independently audit the same documents, research during AICA's development found they typically agree on only 1.2%–14% of their observations—meaning even experienced professionals identify different gaps depending on their individual judgment.
AICA achieves approximately 50% overlap with multiple human auditors, delivering significantly more consistent and repeatable results across 100% of your QMS documentation rather than just the ~30% that traditional audits typically sample.
That said, AICA is designed with "human in the loop" as a fundamental principle. Every observation generated by the AI must be reviewed and approved by a qualified quality professional before the report is finalized. This validation step ensures that AI-generated findings are contextually appropriate for your specific organization and products. You have complete control over which observations are included in the final report.
No specialized technical expertise is required. If you can upload documents to a cloud platform (similar to Dropbox or Google Drive), review audit reports and compliance findings, and navigate a web-based interface, then you have all the technical skills needed to use AICA effectively. The platform was designed by regulatory professionals for regulatory professionals, with an intuitive interface that doesn't require IT background or coding knowledge.
AICA is priced through a hybrid model combining an annual platform subscription with a per-page usage fee for documents analyzed — structured the same way leading compliance platforms are priced. Rather than publishing a static rate card, we scope pricing through a brief discovery conversation, which ultimately works in your favor, ensuring you're only paying for the capacity you'll actually use.
Just submit the form at the bottom of this page and let us know you're interested. There's no commitment. Whether you want a live demo, have a specific question, or just want to understand how AICA fits into your compliance workflow, we'll follow up often within one business day.
Most teams start with a quick introductory conversation where we learn about your auditing needs, walk through the platform, and discuss how AICA would work with your specific regulatory requirements. From there, onboarding is simple. Most teams are up and running within 1–2 weeks. Don't hesitate to get in touch!
We're expanding AICA's regulatory coverage to medical devices and seeking partners to help shape what comes next. Submit our general inquiry form or email us to discuss roadmap alignment for devices. If you're a medical device or medtech firm interested in using AICA, we want to hear from you.
The FDA Group has conducted thousands of audits across every segment of the life sciences industry. That experience is the foundation of AICA. It wasn’t built from theory or generic regulatory datasets. It was shaped by the real-world judgment of the auditors who’ve spent decades conducting inspections, identifying systemic failures, and guiding remediation.
Those same experts helped train and refine AICA so it evaluates quality systems the way experienced regulatory auditors actually do. Not just AI trained on regulations, but AI informed by how auditors think.
For the first time, life sciences companies can run AI-driven compliance audits without pulling their teams off higher-value work.
AICA handles the heavy lifting — cross-referencing regulations, flagging gaps, and generating audit-ready reports — so your team can focus on the decisions that actually move your programs forward. If you're spending more time preparing for audits than acting on what they find, we should talk.”
CONTACT US
Whether you're ready for a free demo or just have questions, we'd love to hear from you.
Submit the form and we'll follow up within one business day to answer your questions, and if you're interested, schedule a free demo session so you can see if AICA is a fit.
Don’t worry—we respect your privacy as much as you do. Your information will not be shared with third parties.
Submit our general inquiry form or email Alan Greathouse directly at [email protected].